- Home
- PDSB vs TNYA Comparison
PDSB vs TNYA Comparison
Compare PDSB & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- TNYA
- Stock Information
- Founded
- PDSB 2005
- TNYA 2016
- Country
- PDSB United States
- TNYA United States
- Employees
- PDSB N/A
- TNYA N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- PDSB Health Care
- TNYA Health Care
- Exchange
- PDSB Nasdaq
- TNYA Nasdaq
- Market Cap
- PDSB 72.2M
- TNYA 73.8M
- IPO Year
- PDSB N/A
- TNYA 2021
- Fundamental
- Price
- PDSB $1.24
- TNYA $0.69
- Analyst Decision
- PDSB Strong Buy
- TNYA Strong Buy
- Analyst Count
- PDSB 2
- TNYA 5
- Target Price
- PDSB $10.00
- TNYA $8.60
- AVG Volume (30 Days)
- PDSB 473.1K
- TNYA 2.3M
- Earning Date
- PDSB 08-12-2025
- TNYA 08-07-2025
- Dividend Yield
- PDSB N/A
- TNYA N/A
- EPS Growth
- PDSB N/A
- TNYA N/A
- EPS
- PDSB N/A
- TNYA N/A
- Revenue
- PDSB N/A
- TNYA N/A
- Revenue This Year
- PDSB N/A
- TNYA N/A
- Revenue Next Year
- PDSB N/A
- TNYA N/A
- P/E Ratio
- PDSB N/A
- TNYA N/A
- Revenue Growth
- PDSB N/A
- TNYA N/A
- 52 Week Low
- PDSB $0.85
- TNYA $0.36
- 52 Week High
- PDSB $4.42
- TNYA $4.06
- Technical
- Relative Strength Index (RSI)
- PDSB 39.29
- TNYA 62.18
- Support Level
- PDSB $1.20
- TNYA $0.58
- Resistance Level
- PDSB $1.40
- TNYA $0.70
- Average True Range (ATR)
- PDSB 0.10
- TNYA 0.05
- MACD
- PDSB -0.03
- TNYA 0.00
- Stochastic Oscillator
- PDSB 12.50
- TNYA 93.66
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.